Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3692852011 | Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3692853018 | Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and clioquinol 30 milligram/1 gram conventional release cutaneous ointment (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment | est un(e) (attribut) | Betamethasone and clioquinol only product in cutaneous dose form | true | Inferred relationship | Some | ||
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment | Plays role | Antiprotozoal therapeutic role | true | Inferred relationship | Some | ||
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment | Plays role | Antifungal therapeutic role (role) | true | Inferred relationship | Some | ||
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment | est un(e) (attribut) | Product containing betamethasone and clioquinol (medicinal product) | false | Inferred relationship | Some | ||
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment | a pour principe actif (attribut) | Betamethasone | false | Inferred relationship | Some | ||
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment | a pour principe actif (attribut) | Adrenal hormone | false | Inferred relationship | Some | ||
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment | a pour principe actif (attribut) | Corticosterone | false | Inferred relationship | Some | ||
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment | a pour principe actif (attribut) | Adrenal hormone agent (substance) | false | Inferred relationship | Some | ||
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment | a pour principe actif (attribut) | Skin agent (substance) | false | Inferred relationship | Some | ||
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment | a pour principe actif (attribut) | Skin antifungal agent | false | Inferred relationship | Some | ||
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment | a pour principe actif (attribut) | Hydroxychloroquine (substance) | false | Inferred relationship | Some | ||
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment | a pour principe actif (attribut) | Hydrocortisone (substance) | false | Inferred relationship | Some | ||
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment | a pour principe actif (attribut) | Clioquinol (substance) | false | Inferred relationship | Some | ||
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment | a pour principe actif (attribut) | Local anti-infective (substance) | false | Inferred relationship | Some | ||
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment | a pour principe actif (attribut) | Skin agent (substance) | false | Inferred relationship | Some | ||
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment | a une forme pharmaceutique (attribut) | Cutaneous AND/OR transdermal dosage form | false | Inferred relationship | Some | ||
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment | a pour principe actif (attribut) | Glucocorticoid hormone | false | Inferred relationship | Some | ||
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment | a une forme pharmaceutique (attribut) | Ointment | false | Inferred relationship | Some | ||
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment | a une forme pharmaceutique (attribut) | Cutaneous ointment | true | Inferred relationship | Some | ||
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment | est un(e) (attribut) | Product containing clioquinol in topical dosage form (medicinal product form) | false | Inferred relationship | Some | ||
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment | Has concentration strength denominator unit | g | true | Inferred relationship | Some | 2 | |
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment | est un(e) (attribut) | Product containing betamethasone valerate in topical dosage form (medicinal product form) | false | Inferred relationship | Some | ||
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment | Has concentration strength denominator unit | g | true | Inferred relationship | Some | 1 | |
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment | Has concentration strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 2 | |
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment | Has concentration strength denominator value | un | false | Inferred relationship | Some | 2 | |
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment | Count of base of active ingredient | deux | false | Inferred relationship | Some | ||
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment | Has concentration strength denominator value | un | false | Inferred relationship | Some | 1 | |
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment | Has concentration strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 1 | |
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment | Has precise active ingredient | Clioquinol (substance) | true | Inferred relationship | Some | 2 | |
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment | Has concentration strength numerator value (attribute) | 30 (qualifier value) | false | Inferred relationship | Some | 2 | |
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment | Has basis of strength substance (attribute) | Clioquinol (substance) | true | Inferred relationship | Some | 2 | |
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment | Has basis of strength substance (attribute) | Betamethasone | true | Inferred relationship | Some | 1 | |
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment | Has concentration strength numerator value (attribute) | un | false | Inferred relationship | Some | 1 | |
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment | Has precise active ingredient | Betamethasone valerate (substance) | true | Inferred relationship | Some | 1 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Canada English language reference set (foundation metadata concept)
Description inactivation indicator reference set